• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过体外产生的致耐受性树突状细胞预防同种异体移植排斥反应。

Prevention of allograft rejection by in vitro generated tolerogenic dendritic cells.

作者信息

Ichim Thomas E, Zhong Robert, Min Wei-Ping

机构信息

Department of Surgery, University of Western Ontario, London, Ont., Canada.

出版信息

Transpl Immunol. 2003 Jul-Sep;11(3-4):295-306. doi: 10.1016/S0966-3274(03)00048-0.

DOI:10.1016/S0966-3274(03)00048-0
PMID:12967783
Abstract

Achieving immunological tolerance in transplantation has been a long sought-after goal since the 1960s. It is, therefore, interesting that the dendritic cells (DC), which are classically known as the most potent stimulators of T cell activation, are now also considered putative tools for tolerance induction. In line with this, much work has been performed using DC for vaccination and immune stimulation. Recently, great interest has been generated regarding the ability of DC to act as immune regulatory cells. Specific subsets of DC or immature DC (iDC) appear to be responsible for maintaining self-tolerance. In this review we will highlight our efforts at elucidating the contribution of DC in transplant tolerant in mice. Specifically, four strategies will be outlined that are currently being used for the generation of DC that have tolerogenic properties in the prevention of allograft rejection. The present study demonstrates that modulated iDC with blunted T cell stimulatory or antigen presentation abilities can afford transplant tolerance by minimizing T cell activation and proinflammatory cytokine production. Moreover, in an alternate strategy, normally matured DC have also been modulated such that alloreactive T cells are specifically targeted for deletion.

摘要

自20世纪60年代以来,在移植中实现免疫耐受一直是人们长期追求的目标。因此,有趣的是,树突状细胞(DC)传统上被认为是T细胞激活的最有力刺激物,现在也被视为诱导耐受的潜在工具。与此一致的是,已经开展了许多使用DC进行疫苗接种和免疫刺激的工作。最近,人们对DC作为免疫调节细胞的能力产生了极大兴趣。DC的特定亚群或未成熟DC(iDC)似乎负责维持自身耐受。在这篇综述中,我们将重点介绍我们在阐明DC对小鼠移植耐受的贡献方面所做的努力。具体而言,将概述目前用于生成具有致耐受性特性的DC以预防同种异体移植排斥的四种策略。本研究表明,具有减弱的T细胞刺激或抗原呈递能力的经调节的iDC可以通过最小化T细胞激活和促炎细胞因子产生来实现移植耐受。此外,在另一种策略中,正常成熟的DC也经过调节,使得同种异体反应性T细胞被特异性靶向清除。

相似文献

1
Prevention of allograft rejection by in vitro generated tolerogenic dendritic cells.通过体外产生的致耐受性树突状细胞预防同种异体移植排斥反应。
Transpl Immunol. 2003 Jul-Sep;11(3-4):295-306. doi: 10.1016/S0966-3274(03)00048-0.
2
IL-12p40-overexpressing immature dendritic cells induce T cell hyporesponsiveness in vitro but accelerate allograft rejection in vivo: role of NK cell activation and interferon-gamma production.白细胞介素-12p40过表达的未成熟树突状细胞在体外诱导T细胞低反应性,但在体内加速同种异体移植排斥反应:自然杀伤细胞激活和γ干扰素产生的作用
Immunol Lett. 2004 Jul 15;94(3):191-9. doi: 10.1016/j.imlet.2004.05.001.
3
Limitations of CD95 ligand-transduced killer dendritic cells to prevent graft rejections.CD95配体转导的杀伤性树突状细胞预防移植物排斥反应的局限性。
Exp Dermatol. 2005 Apr;14(4):273-80. doi: 10.1111/j.0906-6705.2005.00307.x.
4
Decoy NF-kappaB fortified immature dendritic cells maintain laryngeal allograft integrity and provide enhancement of regulatory T cells.诱饵 NF-κB 强化未成熟树突状细胞维持喉移植体完整性,并增强调节性 T 细胞。
Laryngoscope. 2010 Jan;120(1):44-52. doi: 10.1002/lary.20667.
5
Use of rapamycin in the induction of tolerogenic dendritic cells.雷帕霉素在诱导耐受性树突状细胞中的应用。
Handb Exp Pharmacol. 2009(188):215-32. doi: 10.1007/978-3-540-71029-5_10.
6
Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.用于预防同种异体心脏移植排斥反应的治疗性树突状细胞和调节性T细胞的生成。
Clin Immunol. 2008 Jun;127(3):313-21. doi: 10.1016/j.clim.2008.01.013. Epub 2008 Mar 20.
7
Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells.通过用交替活化的树突状细胞调节同种免疫反应来延长皮肤移植存活时间。
Transplantation. 2003 Dec 15;76(11):1608-15. doi: 10.1097/01.TP.0000086340.30817.BA.
8
Suppressive dendritic cells as a tool for controlling allograft rejection in organ transplantation: promises and difficulties.抑制性树突状细胞作为控制器官移植中同种异体移植排斥反应的工具:前景与困难。
Hum Immunol. 2008 Mar;69(3):165-73. doi: 10.1016/j.humimm.2008.01.018. Epub 2008 Feb 29.
9
Prevention of acute and chronic allograft rejection by combinations of tolerogenic dendritic cells.通过诱导免疫耐受的树突状细胞预防急性和慢性移植物排斥反应。
Scand J Immunol. 2011 Feb;73(2):91-101. doi: 10.1111/j.1365-3083.2010.02485.x.
10
Antigen-specific tolerance induced by IL-10 gene modified immature dendritic cells in experimental autoimmune myocarditis in rats.IL-10基因修饰的未成熟树突状细胞诱导大鼠实验性自身免疫性心肌炎中的抗原特异性耐受
Chin Med J (Engl). 2006 Oct 5;119(19):1646-52.

引用本文的文献

1
Exosome removal as a therapeutic adjuvant in cancer.外泌体清除作为癌症治疗的辅助手段。
J Transl Med. 2012 Jun 27;10:134. doi: 10.1186/1479-5876-10-134.
2
Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells.阳离子脂质组成对抗原呈递细胞中 siRNA 的脂质纳米粒制剂基因沉默特性的影响。
Mol Ther. 2011 Dec;19(12):2186-200. doi: 10.1038/mt.2011.190. Epub 2011 Oct 4.
3
Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis.
非扩增脂肪基质血管成分细胞疗法治疗多发性硬化症
J Transl Med. 2009 Apr 24;7:29. doi: 10.1186/1479-5876-7-29.
4
A novel method of modifying immune responses by vaccination with lipiodol-siRNA mixtures.一种通过用碘油-小干扰RNA混合物进行疫苗接种来改变免疫反应的新方法。
J Transl Med. 2006 Jan 3;4:2. doi: 10.1186/1479-5876-4-2.
5
Interferon-gamma-modified dendritic cells suppress B cell function and ameliorate the development of experimental autoimmune myasthenia gravis.干扰素-γ修饰的树突状细胞抑制B细胞功能并改善实验性自身免疫性重症肌无力的发展。
Clin Exp Immunol. 2004 Nov;138(2):230-6. doi: 10.1111/j.1365-2249.2004.02585.x.
6
Induction of RNA interference in dendritic cells.在树突状细胞中诱导RNA干扰。
Immunol Res. 2004;30(2):215-30. doi: 10.1385/IR:30:2:215.